Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.65%271.92M | 19.37%254.96M | 11.07%213.59M | 4.73%192.29M | 26.26%183.61M | -4.32%145.42M | 0.89%151.98M | -2.93%150.64M | -0.88%155.18M | 28.42%156.56M |
| Operating revenue | 6.65%271.92M | 19.37%254.96M | 11.07%213.59M | 4.73%192.29M | 26.26%183.61M | -4.32%145.42M | 0.89%151.98M | -2.93%150.64M | -0.88%155.18M | 28.42%156.56M |
| Cost of revenue | 10.75%29.47M | 18.78%26.61M | 13.20%22.4M | -0.53%19.79M | 21.24%19.89M | 5.54%16.41M | 7.07%15.55M | 11.23%14.52M | -9.35%13.06M | 10.67%14.4M |
| Gross profit | 6.17%242.45M | 19.44%228.36M | 10.83%191.19M | 5.37%172.51M | 26.90%163.71M | -5.44%129.01M | 0.23%136.43M | -4.23%136.12M | -0.02%142.13M | 30.54%142.16M |
| Operating expense | -15.25%198.28M | 48.01%233.96M | 9.67%158.07M | 15.02%144.14M | 16.93%125.32M | 3.26%107.18M | 0.81%103.79M | 5.58%102.96M | 0.75%97.51M | 30.71%96.79M |
| Selling and administrative expenses | 9.64%105.85M | 19.11%96.54M | 10.56%81.05M | 17.95%73.31M | 13.59%62.15M | 3.07%54.71M | 2.23%53.08M | -1.28%51.92M | 4.72%52.6M | 31.81%50.23M |
| -Selling and marketing expense | 4.43%8.06M | 11.50%7.72M | 7.55%6.92M | 0.74%6.43M | 11.70%6.39M | 14.61%5.72M | 23.70%4.99M | -14.52%4.03M | 4.06%4.72M | 7.57%4.53M |
| -General and administrative expense | 10.09%97.79M | 19.82%88.82M | 10.85%74.13M | 19.93%66.88M | 13.82%55.77M | 1.87%49M | 0.43%48.1M | 0.03%47.89M | 4.78%47.88M | 34.83%45.69M |
| Depreciation amortization depletion | 18.52%22.02M | 21.08%18.58M | 3.75%15.34M | 14.71%14.79M | 17.20%12.89M | 116.83%11M | 2.46%5.07M | 13.53%4.95M | 3.49%4.36M | 23.32%4.21M |
| -Depreciation and amortization | 18.52%22.02M | 21.08%18.58M | 3.75%15.34M | 14.71%14.79M | 17.20%12.89M | 116.83%11M | 2.46%5.07M | 13.53%4.95M | 3.49%4.36M | 23.32%4.21M |
| Other operating expenses | -40.75%70.41M | 92.69%118.85M | 10.06%61.68M | 11.46%56.04M | 21.26%50.28M | -9.14%41.46M | -0.98%45.63M | 13.63%46.08M | -4.23%40.56M | 30.21%42.35M |
| Operating profit | 887.54%44.17M | -116.94%-5.61M | 16.74%33.12M | -26.11%28.37M | 75.84%38.39M | -33.11%21.83M | -1.56%32.64M | -25.68%33.16M | -1.67%44.61M | 30.18%45.37M |
| Net non-operating interest income (expenses) | -37.22%-7.29M | -62.00%-5.31M | -52.72%-3.28M | 12.40%-2.15M | 57.05%-2.45M | -50.11%-5.71M | -7.01%-3.8M | -2.69%-3.55M | 27.51%-3.46M | -0.99%-4.77M |
| Non-operating interest income | 80.36%101K | 124.00%56K | 525.00%25K | 300.00%4K | -90.91%1K | 57.14%11K | -22.22%7K | -30.77%9K | -50.00%13K | -48.00%26K |
| Non-operating interest expense | 67.25%4.78M | 132.17%2.86M | 185.61%1.23M | -59.57%431K | -77.18%1.07M | 22.66%4.67M | 6.93%3.81M | 2.56%3.56M | -27.63%3.47M | 0.48%4.8M |
| Total other finance cost | 3.98%2.61M | 21.08%2.51M | 20.52%2.07M | 24.10%1.72M | 32.50%1.39M | --1.05M | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -387.17%-761K | 265K | -1.36M | |||||||
| Other non-operating income (expenses) | ---761K | ---- | ---- | ---- | ---- | ---- | ---1.36M | ---- | ---- | ---- |
| Income before tax | 438.99%36.12M | -135.71%-10.66M | 13.79%29.84M | -27.04%26.22M | 122.87%35.94M | -41.33%16.13M | -7.16%27.49M | -28.06%29.61M | 1.37%41.15M | 32.23%40.6M |
| Income tax | 321.95%10.45M | -159.79%-4.71M | 1.98%7.87M | -26.02%7.72M | 139.01%10.44M | -43.14%4.37M | -8.86%7.68M | -26.96%8.42M | -2.44%11.53M | 26.74%11.82M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 531.60%25.68M | -127.08%-5.95M | 18.72%21.97M | -27.46%18.5M | 116.88%25.51M | -40.63%11.76M | -6.49%19.81M | -28.49%21.18M | 2.93%29.62M | 34.63%28.78M |
| Net income continuous operations | 531.60%25.68M | -127.08%-5.95M | 18.72%21.97M | -27.46%18.5M | 116.88%25.51M | -40.63%11.76M | -6.49%19.81M | -28.49%21.18M | 2.93%29.62M | 34.63%28.78M |
| Noncontrolling interests | 15.57%668K | 355.12%578K | 32.29%127K | -73.11%96K | 950.00%357K | 175.56%34K | 73.84%-45K | -172K | ||
| Net income attributable to the company | 483.15%25.01M | -129.89%-6.53M | 18.65%21.84M | -26.81%18.41M | 114.46%25.15M | -40.93%11.73M | -7.03%19.85M | -27.91%21.35M | 2.93%29.62M | 34.63%28.78M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 483.15%25.01M | -129.89%-6.53M | 18.65%21.84M | -26.81%18.41M | 114.46%25.15M | -40.93%11.73M | -7.03%19.85M | -27.91%21.35M | 2.93%29.62M | 34.63%28.78M |
| Diluted earnings per share | 476.47%0.064 | -130.36%-0.017 | 19.15%0.056 | -27.69%0.047 | 41.30%0.065 | -41.36%0.046 | -7.69%0.0785 | -27.78%0.085 | 3.28%0.1177 | 32.61%0.1139 |
| Basic earnings per share | 476.47%0.064 | -130.36%-0.017 | 19.15%0.056 | -26.56%0.047 | 42.22%0.064 | -42.64%0.045 | -7.69%0.0785 | -27.20%0.085 | 2.46%0.1167 | 32.61%0.1139 |
| Dividend per share | 8.51%0.051 | 6.82%0.047 | 2.33%0.044 | 104.76%0.043 | -55.91%0.021 | -8.93%0.0476 | -29.11%0.0523 | -10.23%0.0738 | 14.29%0.0822 | 136.92%0.0719 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |